Pharmacodynamic Effects of Low-dose Rivaroxaban With Antiplatelet Therapies

NCT03718429 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Peripheral Arterial Disease
Atrial Fibrillation

Interventions

DRUG: Rivaroxaban 2.5 mg Tablet

Sponsor

University of Florida

Collaborators

[object Object]